Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Connective and Soft Tissue

Explore clinical trials studying Neoplasms, Connective and Soft Tissue. Study availability and eligibility vary by location and protocol.

2,735 public trials 587 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Connective and Soft Tissue trial results

Completed

Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors

NCT02095132

Conditions
Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +37 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • UCSF Medical Center-Parnassus San Francisco, California, United States
View all 24 locations
View Trial Details
Completed

Quality of Life of Patients With Desmoid-type Fibromatosis

NCT04289077

Conditions
Desmoid Tumor, Desmoid Tumors, Desmoid-Type Fibromatosis, +6 more
Locations
  • 3. Antoni van Leeuwenhoek Ziekenhuis (AVL) / The Netherlands Cancer Instituut , Amsterdam, The Netherlands Amsterdam, Netherlands
  • Radboud University Medical Center (MC), Nijmegen, The Netherlands Nijmegen, Netherlands
  • Erasmus MC Cancer Institute Rotterdam, Netherlands
  • Royal Marsden NHS Foundation Trust London, United Kingdom
View Trial Details
Completed

Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including Central Nervous System Tumors

NCT03245151

Conditions
Central Nervous System Neoplasms, Disease Attributes, Glioma, +21 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
  • Miller Children's and Women's Hospital Long Beach, California, United States
View all 50 locations
View Trial Details
Completed

Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare Cancers

NCT02034110

Conditions
Biliary Tract Diseases, Biliary Tract Neoplasms, Blood Protein Disorders, +35 more
Locations
  • Novartis Investigative Site Little Rock, Arkansas, United States
  • Novartis Investigative Site Santa Monica, California, United States
  • Novartis Investigative Site Bethesda, Maryland, United States
  • Novartis Investigative Site Boston, Massachusetts, United States
View all 41 locations
View Trial Details

Related conditions